Moreover, SARS-CoV-2 causes ACE/ACE2 balance disruption and RAAS activation, which leads ultimately to COVID-19 progression, especially in the patient with comorbidities, such as hypertension, diabetes mellitus, and cardiovascular disease [32, 33]. Here, ACE is linked to hypertensive disorder.